Percutaneous Biopsy before Interventional Oncologic Therapy: Current Status

Journal of Vascular and Interventional Radiology

Volumn 19, Issue 7, 2008, Pages 973-979

  Brown, Daniel B ^a   Gonsalves, Carin F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HEALTH HAZARD; HUMAN; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 45549100958     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.02.021     Document Type: Note

References (51)

1. Bialecki E.S., Ezenekwe A.M., Brunt E.M., et al. Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma. Clin Gastroenterol Hepatol 4 (2006) 361-368
2. Marsh J.W., and Dvorchik I. Should we biopsy each liver mass suspicious for hepatocellular carcinoma before liver transplantation?-yes. J Hepatol 43 (2005) 558-562
3. Stigliano R., and Burroughs A.K. Should we biopsy each liver mass suspicious for HCC before liver transplantation?-no, please don't. J Hepatol 43 (2005) 563-568
4. Caturelli E., Biasini E., Bartolucci F., et al. Diagnosis of hepatocellular carcinoma complicating liver cirrhosis: utility of repeat ultrasound-guided biopsy after unsuccessful first sampling. Cardiovasc Intervent Radiol 25 (2002) 295-299
5. Caturelli E., Solmi L., Anti M., et al. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 53 (2004) 1356-1362
6. Torzilli G., Minagawa M., Takayama T., et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 30 (1999) 889-893
7. Torzilli G., Olivari N., Del Fabbro D., et al. Indication and contraindication for hepatic resection for liver tumors without fine-needle biopsy: validation and extension of an Eastern approach in a Western community hospital. Liver Transpl 10 suppl (2004) S30-S33
8. Yao F.Y., Hirose R., LaBerge J.M., et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 11 (2005) 1505-1514
9. Bharat A., Brown D.B., Crippin J.S., et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 203 (2006) 411-420
10. Freeman R.B., Mithoefer A., Ruthazer R., et al. Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver Transpl 12 (2006) 1504-1511
11. Brunetti E., Bruno R., Marangio A., Crippa F.G., Filice C., and Caturelli E. Is second biopsy helpful in the diagnosis of hepatocellular carcinoma with a first negative biopsy?. Am J Gastroenterol 95 (2000) 3688-3689
12. Durand F., Regimbeau J.M., Belghiti J., et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 35 (2001) 254-258
13. Huang G.T., Sheu J.C., Yang P.M., Lee H.S., Wang T.H., and Chen D.S. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma-a study based on 420 patients. J Hepatol 25 (1996) 334-338
14. Pawlik T.M., Gleisner A.L., Anders R.A., Assumpcao L., Maley W., and Choti M.A. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg 245 (2007) 435-442
15. Salomao D.R., Lloyd R.V., and Goellner J.R. Hepatocellular carcinoma: needle biopsy findings in 74 cases. Diagn Cytopathol 16 (1997) 8-13
16. Scholmerich J., and Schacherer D. Diagnostic biopsy for hepatocellular carcinoma in cirrhosis: useful, necessary, dangerous, or academic sport?. Gut 53 (2004) 1224-1226
17. Stigliano R., Marelli L., Yu D., Davies N., Patch D., and Burroughs A.K. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 33 (2007) 437-447
18. Bedenne L., Mottot C., Courtois B., et al. Is the Tru-Cut needle more efficient than the fine needle in the diagnosis of hepatic lesions?. Comparative study of 45 echography-guided punctures. Gastroenterol Clin Biol 14 (1990) 62-66
19. Cochand-Priollet B., Chagnon S., Ferrand J., Blery M., Hoang C., and Galian A. Comparison of cytologic examination of smears and histologic examination of tissue cores obtained by fine needle aspiration biopsy of the liver. Acta Cytol 31 (1987) 476-480
20. Ryd W., Hagmar B., and Eriksson O. Local tumour cell seeding by fine-needle aspiration biopsy. A semiquantitative study. Acta Pathol Microbiol Immunol Scand (A) 91 (1983) 17-21
21. Saborido B.P., Diaz J.C., de Los Galanes S.J., et al. Does preoperative fine needle aspiration-biopsy produce tumor recurrence in patients following liver transplantation for hepatocellular carcinoma?. Transplant Proc 37 (2005) 3874-3877
22. Cillo U., Vitale A., Bassanello M., et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 239 (2004) 150-159
23. Tamura S., Kato T., Berho M., et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 136 (2001) 25-30
24. Volpe A., Kachura J.R., Geddie W.R., et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 178 (2007) 379-386
25. Volpe A., Panzarella T., Rendon R.A., Haider M.A., Kondylis F.I., and Jewett M.A. The natural history of incidentally detected small renal masses. Cancer 100 (2004) 738-745
26. Lane B.R., Samplaski M.K., Herts B.R., Zhou M., Novick A.C., and Campbell S.C. Renal mass biopsy-a renaissance?. J Urol 179 (2008) 20-27
27. Silverman S.G., Gan Y.U., Mortele K.J., Tuncali K., and Cibas E.S. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology 240 (2006) 6-22
28. Wolf Jr. J.S. Evaluation and management of solid and cystic renal masses. J Urol 159 (1998) 1120-1133
29. Hara I., Miyake H., Hara S., Arakawa S., Hanioka K., and Kamidono S. Role of percutaneous image-guided biopsy in the evaluation of renal masses. Urol Int 67 (2001) 199-202
30. Lechevallier E., Andre M., Barriol D., et al. Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 216 (2000) 506-510
31. Dechet C.B., Zincke H., Sebo T.J., et al. Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol 169 (2003) 71-74
32. Ralls P.W., Barakos J.A., Kaptein E.M., et al. Renal biopsy-related hemorrhage: frequency and comparison of CT and sonography. J Comput Assist Tomogr 11 (1987) 1031-1034
33. Vassiliades V.G., and Bernardino M.E. Percutaneous renal and adrenal biopsies. Cardiovasc Intervent Radiol 14 (1991) 50-54
34. Heilbrun M.E., Zagoria R.J., Garvin A.J., et al. CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation. AJR Am J Roentgenol 188 (2007) 1500-1505
35. Elsayes K.M., Narra V.R., Yin Y., Mukundan G., Lammle M., and Brown J.J. Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging. Radiographics 25 (2005) 1299-1320
36. Kunkle D.A., Crispen P.L., Chen D.Y., Greenberg R.E., and Uzzo R.G. Enhancing renal masses with zero net growth during active surveillance. J Urol 177 (2007) 849-853
37. Wehle M.J., Thiel D.D., Petrou S.P., Young P.R., Frank I., and Karsteadt N. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology 64 (2004) 49-52
38. Moch H., Gasser T., Amin M.B., Torhorst J., Sauter G., and Mihatsch M.J. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 89 (2000) 604-614
39. Nativ O., Sabo E., Raviv G., Madjar S., Halachmi S., and Moskovitz B. The impact of tumor size on clinical outcome in patients with localized renal cell carcinoma treated by radical nephrectomy. J Urol 158 (1997) 729-732
40. Targonski P.V., Frank W., Stuhldreher D., and Guinan P.D. Value of tumor size in predicting survival from renal cell carcinoma among tumors, nodes and metastases stage 1 and stage 2 patients. J Urol 152 (1994) 1389-1392
41. Yoshino S., Kato M., and Okada K. Evaluation of the prognostic significance of microvessel count and tumor size in renal cell carcinoma. Int J Urol 5 (1998) 119-123
42. Lau W.K., Cheville J.C., Blute M.L., Weaver A.L., and Zincke H. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Urology 59 (2002) 532-537
43. Schlomer B., Figenshau R.S., Yan Y., Venkatesh R., and Bhayani S.B. Pathological features of renal neoplasms classified by size and symptomatology. J Urol 176 (2006) 1317-1320
44. Hsu R.M., Chan D.Y., and Siegelman S.S. Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype. AJR Am J Roentgenol 182 (2004) 551-557
45. Lebret T., Poulain J.E., Molinie V., et al. Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 178 (2007) 1184-1148
46. Bui M.H., Seligson D., Han K.R., et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9 (2003) 802-811
47. Bonzanini M., Pea M., Martignoni G., et al. Preoperative diagnosis of renal angiomyolipoma: fine needle aspiration cytology and immunocytochemical characterization. Pathology 26 (1994) 170-175
48. Beland M.D., Mayo-Smith W.W., Dupuy D.E., Cronan J.J., and DeLellis R.A. Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate?. AJR Am J Roentgenol 188 (2007) 792-797
49. Barocas D.A., Mathew S., DelPizzo J.J., et al. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen. Br J Urol Int 99 (2007) 290-295
50. Cohen H.T., and McGovern F.J. Renal-cell carcinoma. N Engl J Med 353 (2005) 2477-2490
51. Herrmann E., Brinkmann O.A., Bode M.E., et al. Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracil. Eur Urol 51 (2007) 1625-1631